News
-
-
PRESS RELEASE
Curatis and Neupharma announce exclusive licensing agreement to develop and market corticorelin (C-PTBE-01) for the treatment of peritumoral brain edema in Japan
Curatis Holding AG and Neupharma announce exclusive agreement to develop and market corticorelin (C-PTBE-01) for peritumoral brain edema treatment in Japan. Agreement involves upfront, milestone payments, and royalties -
PRESS RELEASE
Klöckner & Co achieves considerable increase in operating income in fiscal year 2025
Klöckner & Co SE achieves significant increase in operating income to €171 million in fiscal year 2025 despite sales decline to €6.4 billion. Positive outlook for 2026 amidst strategic decisions and business combination with Worthington Steel -
-
PRESS RELEASE
Sandoz issues CHF 550 million in bonds and extends its USD 2 billion revolving credit facility by one year
Sandoz Group AG issues CHF 550 million in bonds & extends USD 2 billion revolving credit facility. Bonds for refinancing & general corporate purposes. Extension strengthens balance sheet -
-
-
REGULATED PRESS RELEASE
TINC publishes excellent results with a record investment year as the basis for future profit growth
TINC announces excellent results and record investment year, resulting in increased profit growth and shareholder distribution. Diversification and strategic investments play key roles -
PRESS RELEASE
Elis: Full-year 2025 results
-
PRESS RELEASE
Avolta reports strong 2025, advancing on sales, profits and cash generation, proposes higher dividend and announces new share buyback
Avolta AG reports strong 2025 results with increased sales, profits, and cash generation. They propose a higher dividend and announce a new share buyback program
